Biotech VCs move upstream in China’s scientific pipelines as competition grows fiercer For some U.S. investors, the focus has increasingly turned toward early-stage assets

https://www.statnews.com/2026/03/31/venture-capital-moves-upstream-chase-china-biotech-deals-pre-publication/ By Brian YangMarch 31, 2026